Menu
Menu
Brothers TD, Bonn M, Lewer D, Comeau E, Kim I, Webster D, Hayward A, Harris M. Social and structural determinants of injection drug use-associated bacterial and fungal infections: A qualitative systematic review and thematic synthesis. Addiction. 2023 May 12. https://doi.org/10.1111/add.16257. (This work was featured in an interview in the Addiction journal podcast, available at https://shows.acast.com/addiction-audio/episodes/bacterial-infections-and-social-determinants-of-health-with-)
Gallagher, C., Brunelle, C. (2023). Heterogeneity In Women’s Trauma Histories: Impact On Substance Use Disorder Severity. Journal of Trauma & Dissociation. 24(3). https://doi.org/10.1080/15299732.2023.2181476
Bonn M, Palayew A, Touesnard N, Brothers TD, Bodkin C. Safe Supply In The Midst of a Crisis of Unregulated Toxic Drug Deaths – A Commentary on Roberts and Humphreys. (2023). J Stud Alcohol Drugs. 2023 Jun 8. https://doi.org/10.15288/jsad.23-00153
Ali F, Russell C, Greer A, Bonn M, Werb D, Rehm J. (2023). “2.5 g, I could do that before noon”: a qualitative study on people who use drugs’ perspectives on the impacts of British Columbia’s decriminalization of illegal drugs threshold limit. Subst Abuse Treat Prev Policy, 18(1):32. https://doi.org/10.1186/s13011-023-00547-w
Mahu, I.T., Conrod, P.J., Barrett, S.P., Sako, A., Swansburg, J. & Stewart, S.H. (2023). The four-factor personality model and its qualitative correlates among opioid agonist therapy clients. Frontiers in Psychiatry, 14, 1129274. https://doi.org/10.3389/fpsyt.2023.1129274
Snell, G., Marshall, A.D.,van Gennip, J., Bonn, M., Butler-McPhee, J., Cooper, C.L., Kronfli, N., Williams, S., Bruneau, J., Feld, J.J., Janjua, N.Z., Klein, M., Cunningham, N., Grebely, J., Bartlett, S.R. (2023). Public reimbursement policies in Canada for direct-acting antiviraltreatment of hepatitis C virus infection: A descriptive study.Canadian Liver Journal July 2023. doi:10.3138/canlivj-2022-0040
Gallagher, C., Brunelle, C. (2023) Heterogeneity In Women’s Trauma Histories: Impact On Substance Use Disorder Severity. Journal of Trauma & Dissociation. 24(3). https://doi.org/10.1080/15299732.2023.2181476
Bonn M, Palayew A, Touesnard N, Brothers TD, Bodkin C. Safe Supply In The Midst of a Crisis of Unregulated Toxic Drug Deaths – A Commentary on Roberts and Humphreys (2023). J Stud Alcohol Drugs. 2023 Jun 8. https://doi.org/10.15288/jsad.23-00153
Ali F, Russell C, Greer A, Bonn M, Werb D, Rehm J. “2.5 g, I could do that before noon”: a qualitative study on people who use drugs’ perspectives on the impacts of British Columbia’s decriminalization of illegal drugs threshold limit. Subst Abuse Treat Prev Policy. 2023 Jun 15;18(1):32. https://doi.org/10.1186/s13011-023-00547-w
Mahu, I.T., Conrod, P.J., Barrett, S.P., Sako, A., Swansburg, J. & Stewart, S.H. (2023). The four-factor personality model and its qualitative correlates among opioid agonist therapy clients. Frontiers in Psychiatry, 14, 1129274. https://doi.org/10.3389/fpsyt.2023.1129274
Novitsky, C., Gilin, D., Stewart, S.H., Sherry, S., Yakovenko, I., & Mackinnon, S. (2023 June). Dyadic conflict and gambling behaviour in romantic couples. Talk presented at the Canadian Psychological Association (CPA) National Conference, Toronto, ON.
Snooks, T., Tibbo, P., & Stewart, S.H. (2023 June). Regimens for cannabis administration in trauma exposed individuals: A comparison to benzodiazepine use. Talk presented at the Canadian Psychological Association (CPA) National Conference, Toronto, ON.
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial McAnulty, C., Bastien, G., Socias, E., Bruneau, J., Le Foll, B., Lim, R., Brissette, S., Ledjiar, O., Marsan, S., Talbot, A., Jutras-Aswad, D.
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial Hassan, A., Bozinoff, N., Jutras-Aswad, D., Socias, E., Stewart, S., Lim, R., Le Foll, B.
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial Socias, E., Wood, E., Le Foll, B., Lim, R., Cheol Choi, J., Yin Mok, W., Bruneau, J., Rehm, J., Wild, C., Bozinoff, N., Hassan, A., Jutras-Aswad, D.
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial Jutras-Aswad, D., Le Foll, B., Ahamad, K., Lim, R., Bruneau, J., Fischer, B., Rehm, J., Wild, C., Wood, E., Brissette, S., Gagnon, L., Fikowski, J., Ledjiar, O., Masse, B., Socias, E.
Selective personality-targeted prevention of suicidal ideation in young adolescents: post hoc analysis of data collected in a cluster randomised controlled trial. Grummitt, L.R., Debenham, J., Kelly, E.V., Barrett, E.L., Champion, K.E., Conrod, P.J., Teesson, M., & Newton, N.C.
Multidimensional analysis of adult patients’ care trajectories before a first diagnosis of schizophrenia Vanasse, A., Courteau, J., Courteau, M., Roy, M., Stip, E., Fleury, M., Lesage, A., & Brodeur, S.
Déploiement d’un algorithme de soins en réponse à la crise des opioïdes Annie Talbot, Rania Khemiri, Aïssata Sako, Luc Londei-Leduc, Christine Robin, Suzanne Marcotte, Guenièvre Therrien, Geneviève Goulet, Geneviève Beaudet Hillman, Christine Ouellette, Suzanne Brissette, Marcel Martin, Polina Titova, Pierre Lauzon
Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, Paméla Thébault, Stéphanie Lepage, Suzanne Brissette, Julie Bruneau, Simon Dubreucq, Emmanuel Stip , Jean-François Cailhier, Didier Jutras-Aswad
Framing public health response to the opioid and overdose crisis: are there alternatives to cascade of care model? Stine Bordier Høj, Julie Bruneau, Matthew Hickman
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection.
Andreea Adelina Artenie, Matthew Hickman, Peter Vickerman, Jack Stone, Jason Grebely, Julie Bruneau
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.Elena Argento, M Eugenia Socias, Kanna Hayashi, JinCheol Choi, Lindsay Mackay, Devon Christie, M-J Milloy, Kora DeBeck
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Dimitri Daldegan-Bueno, Lucas O Maia, Michelle Glass, Didier Jutras-Aswad, Benedikt Fischer
Corrigendum: Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences. Noorbakhsh, S., Afzali, M., Boers, E., & Conrod, P.
Substance Use Wellness Tool. Chen, S., Stuart, H.L., Krupa, T., Dobson, K.S., & Stewart, S.H.
Applicability of the four-factor personality vulnerability model for substance misuse in understanding gambling behaviour and gambling problems. Otis, E., Yakovenko, I., Sherry, S., Smith, M., Goldstein, A.L., Ellery, M., Loverock, A., Wild, T.C., Weilgart-Whitehead, B., & Stewart, S.
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada. Wendt, D. C., Marsan, S., Parker, D., Lizzy, K. E., Roper, J., Mushquash, C., Venner, K. L., Lam, A., Swansburg, J., Worth, N., Sorlagas, N., Quach, T., Manoukian, K., Bernett, P., & Radin, S. M.
Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness? Tibbo, P., McKee, K.A., Meyer, J., Crocker, C., Aitchison, K., Lam, R., & Crockford, D.
Does how you use matter? The link between mode of use and cannabis-related risk. Swan, C., Ferro, M., & Thompson, K.
Impact of substance use and mental health comorbidity on health care access in Canada. G Dao, C Brunelle, D Speed
Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT). K MacNeill, C Brunelle, E DiTommaso, B Skelding
Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review. MN Wilson, JA Hayden, E Rhodes, A Robinson, M Asbridge
Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada. Fortier E, Sylvestre MP, Artenie A, Minoyan N, Jutras-Aswad D, Roy É, Grebelyg J, Bruneau J.
Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall B, Bruneau J, Altice F, Henderson G, Rahimi-Movaghar A, Larney S.
Strategies to reduce drug-related harm: responding to the evidence base. Degenhardt L, Wolfe D, Hall W, Hickman M, Chang J, Bruneau J, Farrell M, Griffiths P.
Management of opioid use disorders: a national clinical practice guideline. Bruneau J, Ahamad K, Goyer ME, Poulin G, Selby P, Fischer B, Wild C, Wood E; on behalf of the CIHR CRISM
A prospective observational study of problematic oral cannabinoid use. Ware MA, Martel MO, Jovey R, Lynch ME, Singer J.
Association between binge drug use and suicide attempt among people who inject drugs.
Fournier C, Ghabrash MF, Artenie A, Roy E, Zang G, Bruneau J, Jutras-Aswad D.
Associations between self-reported lifetime history of traumatic brain injuries and current disability assessment in a population sample of Canadian adults. Ilie G, Adlaf EM, Mann RE, Ialomiteanu A, Hamilton H, Rehm J, Asbridge M, Cusimano MD.
Changes in coping and social motives for drinking and alcohol consumption across the menstrual cycle. Joyce KM, Hudson A, O’Connor R, Thompson K, Hodgin M, Perrot T, Stewart SH.
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence. Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.
Distinct pathological profiles of inmates showcasing cluster B personality traits, mental disorders and substance use regarding violent behaviors. Dellazizzo L, Dugré JR, Berwald M, Stafford MC, Côté G, Potvin S, Dumais A.
Does shyness interact with peer group affiliation in predicting substance use in adolescence? Lemyre A, Poliakova N, Vitaro F, Tremblay RE, Boivin M, Bélanger RE.
Drinking to cope with depression mediates the relationship between social avoidance and alcohol problems: A 3-wave, 18-month longitudinal study. Collins JL, Thompson K, Sherry SB, Glowacka M, Stewart SH.
Driving under the influence behaviours among high school students who mix alcohol with energy drinks. Wilson MN, Cumming T, Burkhalter R, Langille DB, Ogilvie R, Asbridge M.
Examining the Association Between Psychiatric Disorders and Cocaine Binges: Results From the COSMO Study. Juteau LC, Roy É, Berbiche D, Arruda N, Bruneau J, Jutras-Aswad D.
Formal and Informal Control of Cannabis: Regular Users’ Experience. Brochu S, Lépine P, Patenaude C, Erickson P.
High and escalating levels of cocaine intake are dissociable from subsequent incentive motivation for the drug in rats. Allain F, Bouayad-Gervais K, Samaha AN.
Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study. Campeau L, Blouin K, Leclerc P, Alary M, Morissette C, Blanchette C, Serhir B, Roy E; SurvUDI Working Group.
Mood-Induced Drinking in Coping with Anxiety-Motivated and Socially Motivated Drinkers: a Lab-Based Experiment Collins JL, Pencer A, Stewart SH.
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M.
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E24, Dore GJ; SIMPLIFY Study Group.
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R.
“I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal. Motta-Ochoa R, Bertrand K, Arruda N, Jutras-Aswad D, Roy É.
A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial. O’Leary-Barrett M, Mâsse B, Pihl RO, Stewart SH, Séguin JR, Conrod PJ.
A Qualitative Study of Addiction Help-Seeking in People with Different Co-occurring Mental Disorders and Substance Use Problems. Motta-Ochoa R, Bertrand K, Flores-Aranda J, Patenaude C, Brunelle N, Landry M, Brochu S.
A Review of CBT Treatments for Substance Use Disorders. Morin JF G, Harris M, Conrod PJ.
Addiction Severity and Suicidal Behaviors Among Persons Entering Treatment. Simoneau H, Ménard JM, Blanchette-Martin N.
Addiction severity index profile of persons who reenter treatment for substance use disorders. Simoneau H, Brochu S.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study. Cunningham EB, Hajarizadeh B, Dalgard O, Amin J, Hellard M, Foster GR, Bruggmann P, Conway B, Backmund M, Robaeys G, Swan T, Marks PS, Quiene S, Applegate TL, Weltman M, Shaw D, Dunlop A, Bruneau J, Midgard H, Bourgeois S, Thurnheer MC, Dore GJ, Grebely J; ACTIVATE Study Group.
Alcohol use among Inuit pregnant women: Validity of alcohol ascertainment measures over time. Fortin M, Muckle G, Jacobson SW, Jacobson JL, Bélanger RE.
An Investigation of the Association Between Shame and Problem Gambling: The Mediating Role of Maladaptive Coping Motives. Schlagintweit HE, Thompson K, Goldstein AL, Stewart SH.
Attentional bias toward alcohol-related stimuli in heavy drinkers: evidence from dynamic eye movement recording. Roy-Charland A, Plamondon A, Homeniuk AS, Flesch CA, Klein RM, Stewart SH.
CRISM Atlantic is sharing research findings from some of our CRISM Atlantic members’ work on mental health, and substance use.
Dao, G., Brunelle, C., & Speed, D. (2019). Impact of substance use and mental health comorbidity on health care access in Canada. Journal of Dual Diagnosis, 15 (4), 260-269. doi:10.1080/15504263.2019.1634856
Harris-Lane, L., Hesson, J., Fowler, K., & Harris, N. (2021). Positive mental health in youth with ADHD: Exploring the role of social support. Canadian Journal of Community Mental Health, 40(1).
Deacon, S. H., Rodriguez, L. M., Elgendi, M., King, F. E., Nogueira-Arjona, R., Sherry, S. B., & Stewart, S. H. (2021). Parenting through a pandemic: Mental health and substance use consequences for couples of mandated homeschooling. Couple and Family Psychology: Research and Practice, 10, 281-293.
Zolopa, C., Burack, J. A., O’Connor, R. M., Corran, C., Lai, J., Bomfim, E., DeGrace, S., Dumont, J., Larney, S., & Wendt, D. C. (2022). Changes in youth mental health, psychological wellbeing, and substance use during the COVID-19 pandemic: A rapid review. Adolescent Research Review, 7, 161–177.
crismatlantic@gmail.com
Dalhousie University
1355 Oxford St., P.O. Box 15000
Halifax, Nova Scotia B3H 4R2